These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2408723)

  • 1. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
    Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
    Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
    Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
    J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
    Ghosh AK; Butler EB
    J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
    Shaw P; Buckman R; Law J; Baumal R; Marks A
    Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic interest of the monoclonal antibody CA1 in malignant pleural effusion.
    Font P; Palacìn A; Font J; Faus R; Molina R; Ballesta AM; Cardesa A; Ingelmo M
    Int J Biol Markers; 1987; 2(3):157-60. PubMed ID: 2453591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
    Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
    Orell SR; Dowling KD
    Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
    Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
    Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
    To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
    J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
    Mezger J; Wilmanns W; Lamerz R
    Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
    Stoetzer OJ; Munker R; Darsow M; Wilmanns W
    Oncol Rep; 1999; 6(2):455-8. PubMed ID: 10023021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.